Back to Search
Start Over
The clinical application of transcutaneous carbon dioxide monitoring during rigid bronchoscopy or microlaryngeal surgery in children.
- Source :
-
Journal of clinical anesthesia [J Clin Anesth] 2025 Jan; Vol. 100, pp. 111692. Date of Electronic Publication: 2024 Nov 23. - Publication Year :
- 2025
-
Abstract
- Study Objective: During rigid bronchoscopies and microlaryngeal surgery (MLS) in children, there is currently no reliable method for managing ventilation strategies based on carbon dioxide (CO <subscript>2</subscript> ) levels. This study aimed to investigate the effects of the clinical implementation of transcutaneous CO <subscript>2</subscript> (tcPCO <subscript>2</subscript> ) monitoring during rigid bronchoscopies or MLS.<br />Design: Prospective observational study.<br />Setting: Operating theatre of a tertiary pediatric hospital, from January 2019 to March 2021.<br />Patients: Children with an age < 18 years, undergoing rigid bronchoscopy or MLS, were eligible for inclusion. Children with tracheostomy and/or skin conditions limiting tcPCO <subscript>2</subscript> monitoring were excluded.<br />Interventions: TcPCO <subscript>2</subscript> monitoring was performed in two groups; blinded before clinical implementation (control group) and visible for ventilation management after clinical implementation (tcPCO <subscript>2</subscript> group).<br />Measurements: The total tcPCO <subscript>2</subscript> load outside of the normal range (35-48 mm Hg) was calculated as the area under the curve (AUC) and compared between the groups. Anesthesiologists in the tcPCO <subscript>2</subscript> group received a questionnaire after each procedure.<br />Main Results: A total of 120 patients were included. No significant differences were found between the two groups in the AUC during the procedure (19,202 (7,863-44,944) vs 17,737 (9,800-47,566) mm Hg · s, P = 0.84) or between different ventilation strategies. The maximal tcPCO <subscript>2</subscript> level was 69.2 (62.1-81.2) mm Hg in the control group and 71.1 (62.8-80.8) mm Hg, (P = 0.85) in the tcPCO <subscript>2</subscript> group. Spontaneous breathing was associated with lower tcPCO <subscript>2</subscript> levels. The general satisfaction score of tcPCO <subscript>2</subscript> monitoring rated by the anesthesiologist was 8.19 (0.96).<br />Conclusions: TcPCO <subscript>2</subscript> levels reached approximately twice the upper limit of the normal range during rigid bronchoscopy and MLS. Availability of tcPCO <subscript>2</subscript> monitoring did not affect these high levels, despite adjustments in strategy. However, tcPCO <subscript>2</subscript> monitoring provides valuable insight in CO <subscript>2</subscript> load and applied ventilation strategies.<br />Competing Interests: Declaration of competing interest The authors have declared no conflict of interest. This study was funded by the Erasmus MC Sophia Foundation (grant number: B1603B).<br /> (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-4529
- Volume :
- 100
- Database :
- MEDLINE
- Journal :
- Journal of clinical anesthesia
- Publication Type :
- Academic Journal
- Accession number :
- 39581128
- Full Text :
- https://doi.org/10.1016/j.jclinane.2024.111692